[go: up one dir, main page]

EA200600402A1 - Клеточные стенки дрожжей для лечения или профилактики гипергликемии или для стабилизации уровня сахара в крови - Google Patents

Клеточные стенки дрожжей для лечения или профилактики гипергликемии или для стабилизации уровня сахара в крови

Info

Publication number
EA200600402A1
EA200600402A1 EA200600402A EA200600402A EA200600402A1 EA 200600402 A1 EA200600402 A1 EA 200600402A1 EA 200600402 A EA200600402 A EA 200600402A EA 200600402 A EA200600402 A EA 200600402A EA 200600402 A1 EA200600402 A1 EA 200600402A1
Authority
EA
Eurasian Patent Office
Prior art keywords
hyperglycemia
prevention
treatment
cell walls
stabilization
Prior art date
Application number
EA200600402A
Other languages
English (en)
Other versions
EA009677B1 (ru
Inventor
Люсьен Лезаффр
Original Assignee
Лезаффр Э Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лезаффр Э Компани filed Critical Лезаффр Э Компани
Publication of EA200600402A1 publication Critical patent/EA200600402A1/ru
Publication of EA009677B1 publication Critical patent/EA009677B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Средства и препараты для лечения или профилактики гипергликемии или для стабилизации гликемии на основе клеточных стенок дрожжей и получение такой терапевтической композиции.
EA200600402A 2003-08-11 2004-08-10 Средство для лечения гипергликемии и его применение EA009677B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03018222 2003-08-11
EP03020253 2003-09-08
PCT/EP2004/008933 WO2005021015A1 (fr) 2003-08-11 2004-08-10 Ecorces de levures pour le traitement ou la prevention de l’hyperglycemie ou pour la stabilisation de la glycemie

Publications (2)

Publication Number Publication Date
EA200600402A1 true EA200600402A1 (ru) 2006-08-25
EA009677B1 EA009677B1 (ru) 2008-02-28

Family

ID=34276722

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200600402A EA009677B1 (ru) 2003-08-11 2004-08-10 Средство для лечения гипергликемии и его применение

Country Status (17)

Country Link
US (2) US7459159B2 (ru)
EP (1) EP1663266B1 (ru)
JP (2) JP4808619B2 (ru)
KR (1) KR101076209B1 (ru)
AU (1) AU2004267928B2 (ru)
BR (1) BRPI0413481A (ru)
CA (1) CA2534791C (ru)
DK (1) DK1663266T3 (ru)
EA (1) EA009677B1 (ru)
ES (1) ES2405934T3 (ru)
MA (1) MA28072A1 (ru)
MX (1) MXPA06001741A (ru)
NO (1) NO20061138L (ru)
NZ (1) NZ545594A (ru)
PL (1) PL1663266T3 (ru)
PT (1) PT1663266E (ru)
WO (1) WO2005021015A1 (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006117566A (ja) * 2004-10-20 2006-05-11 Asahi Breweries Ltd 糖代謝改善剤
JP2007195444A (ja) * 2006-01-26 2007-08-09 Asahi Food & Healthcare Ltd ダイエット飲食品
CN101528245A (zh) * 2006-08-24 2009-09-09 麒麟控股株式会社 用于改善皮肤状态的组合物
JP5238166B2 (ja) * 2007-02-02 2013-07-17 株式会社ヤクルト本社 インターロイキン１２産生抑制剤
FR2919187B1 (fr) * 2007-07-25 2009-11-27 Lesaffre & Cie Utilisation d'ecorces de levure pour le traitement et/ou la prevention de l'hyperinsulinemie.
FR2949064B1 (fr) * 2009-08-14 2011-10-07 Lesaffre & Cie Nouvelles compositions destinees a la prevention et/ou au traitement du diabete
FR2978967B1 (fr) * 2011-08-09 2020-03-20 Lesaffre Et Compagnie Ecorces de levure enrichies en vitamine d2, compositions les contenant, leur procede de preparation, leurs utilisations et dispositif permettant la mise en oeuvre du procede
MD4216C1 (ru) * 2012-08-15 2013-11-30 Институт Микробиологии И Биотехнологии Академии Наук Молдовы Штамм дрожжей Saccharomyces cerevisiae - продуцент маннанов
WO2017179691A1 (ja) * 2016-04-14 2017-10-19 テーブルマーク株式会社 血糖値低下用又はｇｉ値低減用の食品組成物又は組み合わせ
JPWO2017199951A1 (ja) * 2016-05-17 2019-03-14 興人ライフサイエンス株式会社 糖尿病予防効果を有する酵母エキス
IT201600069379A1 (it) * 2016-07-04 2018-01-04 Prosol S P A Composizione sostanzialmente costituita da pareti cellulari di lievito e procedimento per la sua preparazione
ES2989797T3 (es) 2019-01-23 2024-11-27 Lesaffre & Cie Un producto de levadura y una composición que lo comprende, para su uso como agente prebiótico

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5774072A (en) * 1980-10-29 1982-05-10 Yamanouchi Pharmaceut Co Ltd Granule of dietary fiber and its preparation
US4992540A (en) * 1984-11-28 1991-02-12 Massachusetts Institute Of Technology Glucan composition and process for preparation thereof
JPS61167622A (ja) * 1985-01-22 1986-07-29 Asahi Breweries Ltd 糖尿病コントロ−ル剤
US4962094A (en) * 1988-10-28 1990-10-09 Alpha Beta Technology, Inc. Glucan dietary additives
DE69531900T2 (de) * 1993-12-28 2004-09-09 Société des Produits Nestlé S.A. Cerealien enthaltendes lebensmittel mit einem hohen gehalt an löslichen ballaststoffen
DE4413023A1 (de) * 1994-04-18 1995-10-19 Hoechst Ag Verfahren zur Gewinnung eines Faktors mit insulinartiger Wirkung aus Hefeextrakt
AUPN166195A0 (en) * 1995-03-13 1995-04-06 Norvet Research Pty Limited Process for glucan extraction
AUPN398295A0 (en) * 1995-07-05 1995-07-27 Carlton And United Breweries Limited Chemical compounds and processes for their production
US5773426A (en) * 1996-06-07 1998-06-30 Masaki Shirota Proteoglucan and antidiabetic drug thereof
WO1998013056A1 (en) * 1996-09-25 1998-04-02 Gracelinc Limited Beta-glucan products and extraction processes from cereals
DE19835767A1 (de) * 1998-08-07 2000-02-17 Kulicke Werner Michael Verfahren zur Gewinnung hochmolekularer biologisch aktiver immunmodulierender Polysaccharide aus Hefe Saccharomyces Cerevisiae
FR2800076B1 (fr) * 1999-10-22 2003-11-14 Lesaffre & Cie Mannoproteines solubles
ATE407151T1 (de) * 2000-07-03 2008-09-15 Granate Seed Ltd In kaltem wasser lösliches -g(b)-glukanprodukt und verfahren zu dessen herstellung
TWI300714B (en) * 2001-04-27 2008-09-11 Ajinomoto Kk Immunopotentiators
FR2825004B1 (fr) * 2001-05-22 2005-02-11 Bio Springer Produit dietetique satiant
WO2002098440A1 (en) * 2001-06-01 2002-12-12 Ajinomoto Co., Inc. Drugs for diabetes
US20030118989A1 (en) * 2001-12-21 2003-06-26 Carsten Rosenow Differential isolation of cellular content for biological assays

Also Published As

Publication number Publication date
JP2007501829A (ja) 2007-02-01
US20090022758A1 (en) 2009-01-22
EP1663266B1 (fr) 2013-02-20
WO2005021015A1 (fr) 2005-03-10
EP1663266A1 (fr) 2006-06-07
AU2004267928A1 (en) 2005-03-10
EA009677B1 (ru) 2008-02-28
US20060257422A1 (en) 2006-11-16
KR20060037432A (ko) 2006-05-03
CA2534791A1 (fr) 2005-03-10
KR101076209B1 (ko) 2011-10-24
US7459159B2 (en) 2008-12-02
CA2534791C (fr) 2014-10-28
BRPI0413481A (pt) 2006-10-17
MXPA06001741A (es) 2006-05-12
NZ545594A (en) 2009-09-25
ES2405934T3 (es) 2013-06-04
PL1663266T3 (pl) 2013-07-31
DK1663266T3 (da) 2013-05-13
JP2011178794A (ja) 2011-09-15
NO20061138L (no) 2006-05-10
AU2004267928B2 (en) 2010-10-21
MA28072A1 (fr) 2006-08-01
JP4808619B2 (ja) 2011-11-02
PT1663266E (pt) 2013-04-30

Similar Documents

Publication Publication Date Title
EA200501095A1 (ru) Фенилацетамиды и их применение в качестве модуляторов глюкокиназы
EA200601747A1 (ru) Три(цикло)замещённые амидные соединения
EA200600076A1 (ru) Композиции и способы увеличения активности теломеразы
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
DE60236541D1 (de) Inhibitoren von 11-beta-hydroxysteroiddehydrogenase typ 1
NO20053041L (no) Behandling av diabetes.
EA200600402A1 (ru) Клеточные стенки дрожжей для лечения или профилактики гипергликемии или для стабилизации уровня сахара в крови
WO2004043361A3 (en) Compositions and methods for the treatment of natural killer cell related diseases
NO20064347L (no) Substituerte 1,2,3,4-tetrahydroisokinolinderivater
DE60045030D1 (de) Peptid yy (pyy) zur behandlung von glukose stoffwechselkrankheiten
ATE468137T1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
EA200201271A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
BRPI0508700A (pt) uso de sns-595, composição farmacêutica, e, pó liofilizado
UA83057C2 (ru) Замещенные производные диоксида тиазолбензоизотиазола и их применение
EA200601846A1 (ru) Содержащие бензоксазины лекарственные комбинации для лечения заболеваний дыхательных путей
IL173369A (en) Combined pharmaceutical preparation containing g - csf and p1gf effective in stimulating mobilization of peripheral blood progenitor cells
NO20070061L (no) 3-beta-D-ribofuranosyltiazolo[4,5-d]pyridiminnukleosider og anvendelser derav
WO2007002836A3 (en) Methods and compositions for the prevention and treatment of kidney disease
EA200600468A1 (ru) Биполярные транс-каротиноидные соли и их применение
DE60222383D1 (de) Medikament zur verabreichung von amifostin und verwandten wirkstoffen
EA200200853A1 (ru) Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака
WO2004053107A3 (en) Methods for treating diabetes
UA85561C2 (ru) Применение клеточных стенок дрожжей для лечения или профилактики гипергликемии или для стабилизации содержания сахара в крови
DK1697401T3 (da) Tetrapeptid, som regulerer blodglucoseniveauet ved diabetes mellitus
WO2004087117A3 (de) Verwendung von cyclischen aketalen/ketalen zur verbesserten penetration von wirkstoffen in zellen und organen

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU